Effect of Early Mobilization Exercises After Coronary Artery Bypass Graft
Launched by CAIRO UNIVERSITY · Jan 24, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how early mobilization exercises, guided by wearable technology, can help patients recover after coronary artery bypass graft (CABG) surgery. Patients will be divided into three groups: one group will receive standard care, while the other two groups will also participate in different types of exercise—one focusing on aerobic activities like walking or cycling, and the other on resistance exercises, which help build strength. All exercises will be monitored by special wearable devices that check heart activity in real-time to ensure safety.
To join this trial, participants should be stable after their CABG surgery and between the ages of 45 and 65. They should also be able to move their legs and have normal breathing and heart rates. During the study, which starts shortly after surgery and continues until discharge, participants will engage in guided exercises and have their progress measured. This trial is important because it aims to find out if these early exercises can improve recovery outcomes for heart surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1-post -operative clinically stable patients with hemodynamic stability through measurement of respiratory rate( \>8\<30) breaths/min , Heart rate (\>40\<130) beats /min , Spo2\>90% 2-both lower limbs will be physically functional 3-CABG surgery 4-Their age will be ranged from 45-65 years old
- - Exclusion Criteria:
- • 1. Respiratory insufficiency after surgery manifesting hypoxemia with partial pressure of oxygen in arterial blood \<60 mmHg
- • 2. Cardiogenic shock
- • 3. acute renal failure
- • 4. contra-indicated to submaximal exercise test
- • 5. cardiac arrhythmia
- • 6. locomotor/neurological limitation to ambulation
- • 7. physiological compensatory tachycardia in case of (anemia, high tempreture and infection)
- • 8. high blood pressure at rest (systolic blood pressure \>160mmHg or diastolic blood pressure \>100 mmHg -
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
Ahmad Mahdy Ahmad, A.professor
Study Director
Cairo University
NESREEN G EL_NAHAS, professor
Study Chair
Cairo University
Sara Ali AWAD ALLAH, Assistant professor
Principal Investigator
Cairo University
Alaa Eldin Abdelaty Bahy, consultant
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported